Catalyst Wire Dossier Catalyst Wire Dossier

Antaitavir Hasophate Capsules

· Sunshine Lake Pharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Antaitavir Hasophate Capsules, covering 2025-05-14 to 2025-05-14. Get the full timeline:

Most recent: Clinical Trial Update: Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C [Phase 2, Phase 3]

See pricing